Nowadays, the treatment strategies for post-transplant thrombocytopenia include (1) removal of potential causes mentioned previously, (2) support care such as transfusion of platelet, (3) various agents promote the recovery of platelets like thrombopoietin receptor agonists (TPO-RA), recombinant human thrombopoietin (rhTPO), and mesenchymal stem cells (MSC) (3, 6). This evidence concerns the gene MPL and Thrombocytopenia.